Oncology

Latest News

NSCLC | Image: Lung Cancer Foundation of America

Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

By Mary Caffrey
Brooke McCormick

April 28th 2025

Results could give patients with HER2-mutated non–small cell lung cancer (NSCLC) an oral therapy option.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

By AJMC Contributor

April 23rd 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

By Pearl Steinzor

April 23rd 2025

Vitamin D | Image credit: Galina Zhigalova - stock.adobe.com

Vitamin D’s Potential Role in Colorectal Cancer Prevention, Immune Health

By Pearl Steinzor

April 23rd 2025

The study highlighted symptom patterns in the short-term preceding ED visits and unplanned hospitalizations using a previously validated natural language processing a pipeline. | Image credit: Tyler Olson - stock.adobe.com

Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities

By Rose McNulty

April 22nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

September 12th 2013

Segment 3 -Managing Treatment Options and Shared Decision Making

Dr George notes that in an ideal world a multidisciplinary clinic would not be necessary. Multidisciplinary clinics deliver the tools to practitioner to make the best decisions for their patients.

September 12th 2013

Segment 2 - Team-Based Approach to Treatment

In this segment, panelists examine prostate cancer treatment as a model for team-based approach. Panelists agree that there is a need for a multidisciplinary approach to care. There

September 11th 2013

U.S. Cancer-Care Delivery is 'In Crisis': Report

Cancer treatment has grown so complex, many U.S. doctors can't keep up with new information and are offering incorrect treatment, failing to explain options and leaving patients to coordinate their own care.

September 10th 2013

Cancer Patient Stuck with Higher Bills as Obama Pre-existing Condition Plan Runs Low on Cash

Coping with advanced cancer, Bev Veals was in the hospital for chemo this summer when she got a call that her health plan was shutting down. Then, the substitute insurance she was offered wanted her to pay up to $3,125, on top of premiums.

September 9th 2013

Cancer, Managed Care Experts to Lead Talks on How Consumers Will Create Change

Healthcare reform will bring new payment models and new power for consumers, and cancer care delivery will not be immune. With that in mind, The American Journal of Managed Care will bring together experts from the front lines to Baltimore, Maryland, November 14-15 for a conference to share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.

August 27th 2013

AJMC: Study Suggests Link Between Medicare Payment Models and Cancer Supplement Prescription Practices

A new study from The American Journal of Pharmacy Benefits finds that physicians who treat cancer patients may be influenced by the reimbursement policies of the Medicare claim processors that pay them.

August 26th 2013

Best Practices Improve Cancer Care

Katie Sullivan

Adhering to the best practices in cancer care may be the answer many oncologists have been looking for, at least according to one hospital's findings.

August 23rd 2013

Studies Highlight Newly Approved and Novel Multiple Myeloma Treatments

Barbara L. Jones

August 23rd 2013

Pazopanib Maintenance Therapy Delays Relapse of Advanced Ovarian Cancer

Beth Fand Incollingo

August 23rd 2013

Optimal Paclitaxel Schedule Identified for Early-Stage Breast Cancer

Ben Leach

August 23rd 2013

Predicting Treatment Outcomes in Older Adults With AML

Heidi D. Klepin, MD, MS

August 23rd 2013

More Evidence for 10 Years of Tamoxifen in ER+ Breast Cancer

Anita T. Shaffer

August 23rd 2013

Inaugural 'Giants of Cancer Careâ€ Announced: Oncology Luminaries Selected by Peers for Prestigious National Honor

August 23rd 2013

Early Results Robust for New Immunotherapy Agent

Anita T. Shaffer

August 23rd 2013

More Genetic Screening Needed for African-American Breast Cancer Patients

Lauren M. Green

August 22nd 2013

Bruce Feinberg, DO, Discusses Cost Effective Cancer Treatment

Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says cancer treatment is more than clinical guidelines, protocols, or individual drugs.

August 21st 2013

Current Issues in Breast Cancer Treatment: Chernew Leads Discussion with Swain, Newcomer on New Agents, Cost of Care

Nicole Beagin

August 21st 2013

Sequester Forcing Chemo Treatments into Hospital Settings, Costing Taxpayers More in the End

The federal sequester trims Medicare payments for cancer patients receiving chemotherapy in doctors' offices in an effort to save the government money. Instead, it will end up costing more in the long run, according to the president of the American Society of Clinical Oncology (ASCO).

August 21st 2013

Panel Discusses Costly New Oncology Drugs; Study Address Cancer Drug Shortages

Although researchers have made powerful new targeted treatment options available to oncologists who treat breast cancer patients, options such as pertuzumab are associated with high costs which raises questions about access as payers assess the value of treatment.

August 20th 2013

Sequester Forcing Chemo Treatments into Hospitals Costing Taxpayers More in the End

Stanton R. Mehr

August 19th 2013

Drug Shortages Persist in Wake of Surveys

Beth Fand Incollingo Mary K. Caffrey

August 19th 2013

Managed Care Experts and Oncologists Discuss Reimbursement, Access Issues Associated with Expensive New Cancer Therapies

Expert panel convened by the American Journal of Managed Care provides insight into the challenges faced by clinicians and payers when administering cutting-edge cancer medications.

August 19th 2013

Changing the Cancer Landscape

Since the rise of genetics and advanced molecular biology, cancer research is a field that has become almost as obsessed with understanding aberrant metabolism as it is with devising therapies.

August 15th 2013

Michael Kolodziej Says Provider-Payer Connections Key in Quality, Cost-Effective Cancer Care

In order to deliver quality and cost-effective cancer care, Michael Kolodziej, MD, Aetna's national medical director for oncology strategies, says that providers need to get better connected with payers.

August 12th 2013

Cost of Care for Malignant and Benign Renal Masses

Aviva G. Asnis-Alibozek, PA-C Michael J. Fine, MD Paul Russo, MD Trent McLaughlin, BSc(Pharm), PhD Eileen M. Farrelly, MPH Norman LaFrance, MD William Lowrance, MD, MPH

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.

August 8th 2013

Health Reform Will Cost Cancer Patients

Katie Sullivan

In an effort to offset cost increases associated with the Affordable Care Act (ACA), the Obama administration intends to expand hospitals' access of the 340B discount drug plan. While the expansion may sound promising to some, many others worry that the program will threaten the quality of care, as increased participation risks higher potential for abuse. Even worse, the 340B program will likely rise the cost of cancer care.

August 8th 2013

Lung Cancer Pattern Predicts Recurrence

For patients with early-stage lung adenocarcinomas, the histological pattern of the tumor predicts the risk of recurrence and might help guide surgical decisions.

August 1st 2013

Narrowing Physician Access Puts Pharma in a Bind

Katie Sullivan

Oncologists have a reputation to maintain - and according to the latest report from ZS Associates, when it comes to fortifying against pharmaceutical sales representatives, the specialty remains characteristically hardboiled for the second year in a row.

July 30th 2013

Panel Backs Lung Cancer Screening for Smokers

For the first time, government advisers are recommending screening for lung cancer, saying certain current and former heavy smokers should get annual scans to cut their chances of dying of the disease.

July 29th 2013

Segment 7- Healthcare System Challenges

Panelists agreed that the cost of the new agents discussed to treat melanoma will be a challenge, just as the cost of healthcare as a whole in the United States is a major challenge.

...

168 169 170 171 172 173 174 175 176

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions